The research team, led by Jingchun Shen and Xingxing Zhang, built detailed urban energy models of three case-study districts using the City Energy Analyst framework, supplemented with geospatial data from OpenStreetMap and refined in QGIS. The Amsterdam site comprises thirty-five boathouses along the Stadhouderskade canal, hemmed in by street trees and taller neighboring buildings. The Riga district, Daugavgrīva, contains eight mid-rise apartment blocks, a kindergarten and a grocery store. The Borlänge site in Sweden consists of ten low-rise, two-storey houses in the Rymdgatan community. These contrasting morphologies, the authors argue, are precisely what determines whether solar integration can realistically push a district toward net-zero operation.

To capture the influence of climate change, the team generated future weather files for 2050 and 2080 by morphing baseline Typical Meteorological Year data within the CMIP5 framework, and validated the results against the newer CMIP6 SSP2-4.5 middle-of-the-road emissions scenario. The comparison showed nearly identical warming trends and almost complete overlap in solar radiation projections, giving confidence that the principal climatic drivers of building energy demand and photovoltaic generation are robust across both datasets. The projected changes are striking. By 2080, annual mean temperature rises by 3.4 degrees Celsius in Amsterdam, 5.4 degrees in Riga and 4.8 degrees in Borlänge, while cumulative global horizontal irradiance increases by roughly 57, 65 and 210 kilowatt-hours per square metre respectively.

These shifts translate into a fundamental rebalancing of thermal demand. Heating degree days, calculated against an 18-degree base, fall by 35 percent in Amsterdam, 39 percent in Riga and 49 percent in Borlänge by 2080. Cooling degree days, measured against a 24-degree base, surge by 545 percent in Amsterdam and a remarkable 646 percent in Riga, although they rise by only 88 percent in the cooler Swedish context. The study concludes that European districts are moving from heating-dominated to cooling-sensitive demand profiles, a transition that will reshape building design, urban planning and the value of solar-generated electricity, which becomes more consistently available year-round as global irradiance increases.

At the heart of the methodology is an irradiance threshold framework, a deliberately simple but powerful idea. Rather than covering every available surface with panels, the researchers tested five annual radiation thresholds, from zero to 800 kilowatt-hours per square metre per year, placing panels only on surfaces receiving radiation above each cutoff. This allows planners to trade off total energy yield against the levelized cost of electricity, calculated with a 20-year system lifetime, a 5 percent discount rate and operation and maintenance costs set at about 1 percent of annualized capital expenditure. The team also ran sensitivity analyses using a solar learning rate of 24 percent, drawn from Berkeley Lab data on utility-scale photovoltaics, meaning each doubling of cumulative installed capacity reduces costs by roughly a quarter.

The results expose three distinct structural archetypes. Amsterdam’s boathouse district is demand-dominated: high density, heavy shading from adjacent buildings and trees, and severely limited envelope area mean that even with unrestricted panel placement, on-site photovoltaics would cover only 29 percent of current electricity demand, falling to 17 percent by 2080 as consumption climbs 48.3 percent. The recommended irradiance threshold is therefore the lowest tested range of 0 to 200 kilowatt-hours per square metre per year, and the authors argue that Amsterdam’s decarbonization must rely on multi-vector strategies, including higher-efficiency technologies, rooftop integration, flexible storage and an active role for distributed solar in grid decarbonization rather than local self-sufficiency alone.

Riga presents a balanced-to-surplus profile. Mid-rise buildings with favorable façade exposure and moderate density allow photovoltaic generation to exceed annual demand across all scenarios, with demand coverage ranging from 170 to 270 percent. Here the economics favor selectivity: the levelized cost of electricity, ranging from 0.18 to 0.36 US dollars per kilowatt-hour at baseline, reaches its minimum at an irradiance threshold of 600 kilowatt-hours per square metre per year, where self-consumption approaches 55 percent. Under moderate and strong technology-learning scenarios, costs fall by 30 to 50 percent, expanding the range of economically viable installation sites. The authors note that such surplus districts create opportunities for grid export, storage and sector coupling, but also warn that rising shares of variable generation reduce system inertia, requiring adapted market rules and balancing mechanisms of the kind already operating in Nordic electricity markets.

Borlänge, with its low-rise morphology, large roof and façade areas per unit of demand and minimal mutual shading, is surplus-dominated. Photovoltaic potential exceeds district demand by roughly four to five times at low irradiance thresholds and remains about three times higher even at 600 kilowatt-hours per square metre per year. The optimal threshold is 800 kilowatt-hours per square metre per year, where baseline costs of 0.13 to 0.26 dollars per kilowatt-hour reach their lowest point. Because the district is served by a low-carbon district heating network and cooling demand remains limited, total energy consumption rises only 1 percent by 2080 while solar potential grows 15 percent. The authors position Borlänge as an ideal testbed for export-oriented operations, curtailment management and grid-supportive flexibility measures under high renewable penetration.

The study also delivers a nuanced verdict on photovoltaic-thermal hybrid panels, which generate electricity and heat simultaneously. In Amsterdam, where dwellings rely on individual heating systems, the thermal output of hybrid panels directly offsets domestic hot water and space heating demand, keeping self-sufficiency ratios around 30 percent even in future scenarios. In Riga and Borlänge, however, mature district heating networks already supply most thermal demand, and projected reductions in heating needs further diminish the marginal value of additional heat, making electricity-only photovoltaics the more cost-effective choice. The technology-learning analysis adds a final insight: future cost reductions improve the absolute viability of every strategy, but the relative ranking of irradiance thresholds remains stable, confirming that solar access, installation area and demand, not economics alone, are the primary determinants of district-scale solar success.

Subject of Research: Techno-economic assessment of district-scale solar energy integration in three residential districts under future climate conditions

Article Title: Techno-economic assessment of district-scale solar energy integration in three residential districts under future climate conditions

Article References: Shen, J., & Zhang, X. (2026). Techno-economic assessment of district-scale solar energy integration in three residential districts under future climate conditions. Energy Reports, 16, Article 109698. https://doi.org/10.1016/j.egyr.2026.109698

Image Credits: AI Generated

DOI: 10.1016/j.egyr.2026.109698

Keywords: Techno-economic, assessment, district-scale, solar, energy, integration, three, residential, districts, under, future, climate

Metabolic bariatric surgery, historically deemed the gold standard for sustained and effective weight reduction among patients with obesity, has long demonstrated remarkable efficacy not only in weight loss but also in the amelioration of associated metabolic comorbidities such as type 2 diabetes mellitus, hypertension, and dyslipidemia. Techniques such as Roux-en-Y gastric bypass and sleeve gastrectomy alter the anatomy and physiology of the gastrointestinal tract, leading to decreased caloric intake and alterations in gut hormone profiles. Despite its proven benefits, this study indicates a marked downturn in uptake likely influenced by the rising prominence and accessibility of pharmacological interventions.

The glucagon-like peptide-1 receptor agonists represent an innovative class of peptides that mimic endogenous incretin hormones, which are secreted by intestinal L-cells in response to nutrient ingestion. These pharmacotherapeutics enhance glucose-dependent insulin secretion, suppress glucagon release, and delay gastric emptying, thus contributing to appetite suppression and enhanced weight loss. The dramatic increase in GLP-1 RA utilization signals the medical community’s growing confidence in their safety profiles and efficacy, potentially shifting treatment paradigms away from invasive surgical procedures toward more patient-friendly pharmacotherapy.

Notably, the escalating prescription rates of GLP-1 receptor agonists may be attributed to several factors, including improved formulation, expanded indication approvals across various metabolic diseases, and increasing patient acceptance due to the non-invasive nature of the medication. Additionally, advances in molecular engineering have allowed for the development of longer-acting agents that provide sustained therapeutic effects with reduced dosing frequency, enhancing adherence and treatment outcomes.

Surgical intervention, albeit highly effective, is often accompanied by procedural risks, recovery times, and potential complications such as nutrient malabsorption, surgical site infections, or postoperative anatomical alterations. These challenges may deter some eligible patients from pursuing bariatric surgery. In contrast, GLP-1 receptor agonists offer a pharmacologic alternative that minimizes these concerns, providing a compelling treatment strategy especially for individuals with contraindications to surgery or those seeking less invasive options.

From a metabolic standpoint, the incretin-based therapies harness the body’s natural hormonal pathways to modulate energy balance and glucose homeostasis, attributes that are crucial in tackling the multifaceted pathophysiology of obesity. The confluence of improved patient outcomes and quality of life associated with GLP-1 receptor agonists underscores their potential to become central components in comprehensive metabolic health management programs.

The observed decline in bariatric surgical procedures concomitant with the rise in GLP-1 RA use may forecast an ongoing shift in clinical practice patterns. This trend reflects an evolving therapeutic landscape shaped by pharmaceutical innovation and patient-centered care models, which prioritize minimally invasive interventions with durable efficacy and manageable side effect profiles.

Medical professionals are now challenged to understand the long-term implications of this shift, especially in terms of sustained weight loss, metabolic improvement, and cost-effectiveness. While GLP-1 receptor agonists demonstrate promising short- and mid-term results, bariatric surgery remains unparalleled in achieving substantial and lasting weight reduction, posing important questions about patient selection criteria and treatment algorithms.

Moreover, the increasing reliance on pharmacotherapy necessitates vigilant monitoring for adverse effects, potential drug resistance, and adherence challenges, as well as considerations about equity of access given the typically high costs associated with these novel agents. Health systems must balance the benefits of emerging medical treatments with the well-established outcomes of surgical intervention to optimize comprehensive obesity care.

In parallel, ongoing clinical trials and research efforts are essential to delineate the comparative effectiveness of GLP-1 receptor agonists versus metabolic bariatric surgery across diverse patient populations. These investigations will also help clarify long-term safety profiles, mechanistic pathways, and potential synergies when combining surgical and pharmacological approaches.

As the prescribing of GLP-1 receptor agonists continues its upward trajectory, future healthcare models are likely to emphasize individualized treatment regimens that integrate pharmacology, lifestyle modification, and surgical options tailored to patient-specific metabolic and anatomical characteristics. This integrative strategy aims to maximize therapeutic efficacy while minimizing risks and enhancing patient satisfaction.

In summary, the study published in JAMA Surgery sheds light on a transformative period in obesity treatment, marked by a substantial reduction in metabolic bariatric surgeries alongside explosive growth in GLP-1 receptor agonist use. This dynamic is poised to reshape clinical decision-making, resource allocation, and ultimately patient outcomes in the domain of metabolic health and weight management.

Subject of Research: Trends in utilization of metabolic bariatric surgery and glucagon-like peptide-1 receptor agonists in obesity treatment
Article Title: Not specified
News Publication Date: Not specified
References: doi:10.1001/jamasurg.2026.1343
Keywords: Weight loss, Surgery, Metabolic health, Peptides, Agonists